Figure 1.
Correlation of mean relative low-density lipoprotein (LDL) reduction by non-statins and corresponding mean risk reduction of the composite primary endpoint.
Correlation of mean relative low-density lipoprotein (LDL) reduction by non-statins and corresponding mean risk reduction of the composite primary endpoint.
